Table 1 The characteristics of the included meta-analysis.
Study | Included studies | DM course (year) | Age range (year) | Sample Size | OR | 95%CI | P | Risk factors |
|---|---|---|---|---|---|---|---|---|
Merlotti et al.11 | 7 | 3.68–14.73 | 44.62–60.61 | NA | 0.39 | 0.21–0.71 | NA | Bariatric surgery |
Fu et al.12 | 6 | NA | NA | 4471 | 0.7 | 0.58–0.85 | NA | Myopia |
Shi et al.13 | 2 | NA | NA | 152 | 0.37 | 0.13–1.02 | 0.05 | Lipid-lowering drug (< 3y) |
4 | NA | NA | 3477 | 0.8 | 0.64–1.01 | 0.06 | Lipid-lowering drug (> 3y) | |
Qiu et al.14 | 11 | NA | NA | 2890 | 1.19 | 1.11–1.27 | 0 | DM course |
7 | NA | NA | 1720 | 1.45 | 1.20–1.75 | 0.0001 | HbA1c | |
6 | NA | NA | 1856 | 1.25 | 1.00–1.55 | 0.05 | Fasting plasma glucose | |
Song et al.15 | 5 | NA | NA | NA | 1.99 | 1.34–2.95 | 0.001 | Insulin therapy |
7 | NA | NA | NA | 1.22 | 1.10–1.35 |  < 0.01 | Rural residence | |
Cai et al.16 | 56 | NA | NA | NA | 0.68 | 0.86–0.98 |  < 0.02 | Smoking |
Liu et al.17 | 141 | NA | 46.28–70.72 | 362 | 1.5 | 1.20–1.87 | NA | Hypertension |
141 | NA | 46.28–70.72 | 362 | 1.73 | 1.24–2.41 | NA | Gender | |
Zhang et al.18 | 148 | NA | NA | 364 | 0.67 | 0.26–1.73 | 0.4 | Intensive glycemic control |
